Literature DB >> 28695321

Angiogenesis and Lymphangiogenesis in the Adrenocortical Tumors.

Sofia S Pereira1,2,3, Madalena M Costa3, Susana G Guerreiro1,2, Mariana P Monteiro3, Duarte Pignatelli4,5,6.   

Abstract

Adrenocortical tumors (ACT) are common adrenal tumors. The majority of ACTs are non-functioning and benign, while adrenocortical carcinomas (ACC) are rare, usually very aggressive and often metastasized when first diagnosed. Our aim was to assess whether blood and lymph vessel density within ACTs correlate with the malignancy character or tumor functionality. For that, the microvascular distribution was evaluated by immunohistochemistry staining with D2-40 antibody, for lymph vessels and CD-31 antibody, for blood vessels, in ACCs (n = 15), adenomas with Cushing syndrome (n = 9) and non-functioning adenomas (n = 10). The percentage of stained area was quantified by computerized morphometric analysis. D2-40 expression was significantly lower in ACC as compared to adenomas with Cushing syndrome (p < 0.01) and correlated positively with the expression of the steroidogenic acute regulatory protein (StAR) (R2 = 0.553, p < 0.001). CD31 expression was found to be significantly higher in ACC as compared to adenomas with Cushing syndrome (p < 0.05). Our results show that angiogenesis is increased in ACC, suggesting that this phenomenon may have an important role in ACT biological behavior, while lymph vascular density seems to be more closely related to the tumor functional status than malignancy.

Entities:  

Keywords:  Adrenocortical carcinoma; Adrenocortical tumors; Angiogenesis; Lymphangiogenesis

Mesh:

Substances:

Year:  2017        PMID: 28695321     DOI: 10.1007/s12253-017-0259-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  14 in total

1.  Mechanism of adrenal atrophy in Cushing's syndrome due to adrenal tumor.

Authors:  L H KYLE; R J MEYER; J J CANARY
Journal:  N Engl J Med       Date:  1957-07-11       Impact factor: 91.245

Review 2.  Lymphangiogenesis in development and human disease.

Authors:  Kari Alitalo; Tuomas Tammela; Tatiana V Petrova
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

3.  Angiogenesis in human normal and pathologic adrenal cortex.

Authors:  G P Bernini; A Moretti; A G Bonadio; M Menicagli; P Viacava; A G Naccarato; P Iacconi; P Miccoli; A Salvetti
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

4.  Lymph Node Metastases in Papillary and Medullary Thyroid Carcinoma Are Independent of Intratumoral Lymphatic Vessel Density.

Authors:  Filipe Pereira; Sofia S Pereira; Marta Mesquita; Tiago Morais; Madalena M Costa; Pedro Quelhas; Carlos Lopes; Mariana P Monteiro; Valeriano Leite
Journal:  Eur Thyroid J       Date:  2017-03-17

5.  Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.

Authors:  Marc P Pusztaszeri; Walter Seelentag; Fred T Bosman
Journal:  J Histochem Cytochem       Date:  2005-10-18       Impact factor: 2.479

6.  Prognostic utility of quantitative image analysis of microvascular density in prostate cancer.

Authors:  Ugur Ozerdem; Eva M Wojcik; Xiuzhen Duan; Çağatay Erşahin; Güliz A Barkan
Journal:  Pathol Int       Date:  2013-05       Impact factor: 2.534

7.  D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.

Authors:  L Browning; D Bailey; A Parker
Journal:  J Clin Pathol       Date:  2007-07-27       Impact factor: 3.411

8.  Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration.

Authors:  James J Logie; Sadaf Ali; Kathryn M Marshall; Margarete M S Heck; Brian R Walker; Patrick W F Hadoke
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

9.  The emerging role of the molecular marker p27 in the differential diagnosis of adrenocortical tumors.

Authors:  Sofia S Pereira; Tiago Morais; Madalena M Costa; Mariana P Monteiro; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2013-08-28       Impact factor: 3.335

Review 10.  The role of lymphangiogenesis and angiogenesis in tumor metastasis.

Authors:  Roman Paduch
Journal:  Cell Oncol (Dordr)       Date:  2016-04-28       Impact factor: 6.730

View more
  3 in total

1.  Ang-Tie Angiogenic Pathway Is Distinctively Expressed in Benign and Malignant Adrenocortical Tumors.

Authors:  Sofia Oliveira; Sofia S Pereira; Madalena M Costa; Mariana P Monteiro; Duarte Pignatelli
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 2.  The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.

Authors:  Maja Mizdrak; Tina Tičinović Kurir; Joško Božić
Journal:  Biomedicines       Date:  2021-02-10

3.  Adrenocortical Carcinoma Steroid Profiles: In Silico Pan-Cancer Analysis of TCGA Data Uncovers Immunotherapy Targets for Potential Improved Outcomes.

Authors:  João C D Muzzi; Jessica M Magno; Milena A Cardoso; Juliana de Moura; Mauro A A Castro; Bonald C Figueiredo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-14       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.